X
<

Spotlight on ETFs: The iShares NASDAQ Biotechnology ETF

PART:
1 2 3 4
Part 2
Spotlight on ETFs: The iShares NASDAQ Biotechnology ETF PART 2 OF 4

Benefitting from IBB’s Lower Expense Ratio

Expense ratio

The iShares NASDAQ Biotechnology ETF (IBB) is an open-end fund with assets under management of $9.85 billion. The fund charges 0.47% of the investment value as annual fund operating expenses—also called the “expense ratio.” Among the top biotechnology ETFs in the United States, the iShares NASDAQ Biotechnology ETF has one of the lowest expense ratios. But it’s a tad higher than the VanEck Vectors Biotech ETF (BBH) and the SPDR S&P BIOTECH ETF (XBI). IBB offers a dividend yield of 0.20%.

Benefitting from IBB’s Lower Expense Ratio

Interested in BBH? Don't miss the next report.

Receive e-mail alerts for new research on BBH

Success! You are now receiving e-mail alerts for new research. A temporary password for your new Market Realist account has been sent to your e-mail address.

Success! has been added to your Ticker Alerts.

Success! has been added to your Ticker Alerts. Subscriptions can be managed in your user profile.

The fund’s standard deviation for the last three years is 24.29%. Standard deviation measures the variability in the fund’s returns in relation to its average over a certain period. The higher the standard deviation, the higher the fund’s volatility in returns.

Lower spread

The fund’s average spread is 0.06%, the second lowest among the top biotech ETFs in the country. An ETF with a narrow spread is more liquid and probably easier to buy and sell than an ETF with a wider spread. The bid-to-ask spread for a particular ETF is the difference in quoted prices between the best offer to buy and the best offer to sell.

Benefitting from IBB’s Lower Expense Ratio

Portfolio turnover

The fund’s portfolio turnover rate fell consistently from 39% in 2014 to 18% in 2017, which bodes well for fund investors. Normally, a higher portfolio (BIIB)(GILD) turnover leads to additional transaction costs for the fund, which could result in higher taxes when the fund’s shares are held in a taxable account. These costs affect the fund’s performance.

X

Please select a profession that best describes you: